Skip to content

Observation on the clinical effect of cupping assisted treatment of severe pneumonia at Back Shu point

Observation on the clinical effect of cupping assisted treatment of severe pneumonia at Back Shu point

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076958
Enrollment
Unknown
Registered
2023-10-25
Start date
2023-10-30
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pneumonia

Interventions

Experimental group :Locate the following acupoints according to the World Health Organization Standard Acupuncture Channel Location (Western Pacific Region). Point selection: Fei Shu, PI Shu, Shen Shu
Procedure: The patient was asked to lie prone on the bed, and after the point selection site was disinfected, 6 small cupping cups (with an inner diameter of about 3.4cm) were used to adsorption into
Keep an eye on the time to prevent foaming and infection.
Control group:Control group was treated with a sham cupping device (refer to Lee MS,Kim JI,Kong JC,et al.Developing and validating a sham cupping device[J].Acupuncture in medicine:journal of the Briti

Sponsors

Shanghai Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Patients with severe pneumonia who meet the definition of Infectious Disease Society of America/American Thoracic Society (IDSA/ATS); ?Age 18-80 years old; ?Patients or family members are willing to accept cupping treatment, and actively cooperate and sign informed consent.

Exclusion criteria

Exclusion criteria: ?There are contraindications to prone position, such as facial or pelvic fracture, spinal injury or poor stability, multiple injuries, abdominal trauma; ? Can not receive cupping treatment due to various reasons such as pneumothorax, airway injury, local skin injury or skin disease; ? Severe allergy; ?Patients with mental illness, pulmonary encephalopathy coma, shock, or complicated with serious heart, brain, liver, kidney and other diseases and malignant tumors; ?Pregnant and lactating women; ? Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
SPO2;RR;

Secondary

MeasureTime frame
WBC;CRP;PCT;TNF-a;IL-6;IL-10;VT;PS;PEEP;Mechanical ventilation time;PaO2;PaCO2;OI;Lac;TCM symptom rating table;

Countries

China

Contacts

Public ContactLI WEN

Shanghai Seventh People's Hospital

1006864002@qq.com+86 158 0046 7991

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026